Waypoint Bio
Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.
$20M Series A ·
Source: fundraisingfox.com
All 2 rounds ↓Signals
X account@waypointbio · created Jun 1, 2021 (5 years old) · 158 followers
Website registeredApr 25, 2021 (5 years old)
TIMELINE · MONEY RAISED
Waypoint Bio | 1160 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $20M | — | fundraisingfox.com | |
| Seed | undisclosed | — | fundraisingfox.com |
Timeline
- X account created
- Website created
Founders and team
XW
Xinchen Wang Co-founder & CEO@xinchen_w · source: waypointbio.comDP
David Phizicky Co-founder & CSOLinkedIn · source: waypointbio.com
Companies like Waypoint Bio
AA2 Biotherapeutics$80M Series B+ · Jan 2025
TT-Knife$110M Series B+ · Aug 2021
AArsenal BiosciencesSeries B+ · Oct 2025PPushCART TherapeuticsSeed · Jul 2026
TTiltbio$25M Series B+ · May 2025BBreakthru Medicine$60M Series A · Feb 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/waypoint-bio (get a free API key).